Cargando…

Association between remnant cholesterol, metabolic syndrome, and cardiovascular disease: post hoc analysis of a prospective national cohort study

BACKGROUND: Epidemiologic evidence suggested that remnant cholesterol (RC) is associated with the occurrence of cardiovascular disease (CVD). In recent years, RC has been connected with different types of cardiometabolic disorders. We aim to clarify the relationship among RC, metabolic syndrome (Met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Junguo, Hu, Xiangming, Francois, Melissa, Zeng, Ping, Wang, Weimian, Yu, Bingyan, Zhou, Yingling, Dong, Haojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566110/ https://www.ncbi.nlm.nih.gov/pubmed/37821969 http://dx.doi.org/10.1186/s40001-023-01369-z

Ejemplares similares

The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
por: Hu, Xiangming, et al.
Publicado: (2022)

Triglyceride-glucose index is associated with quantitative flow ratio in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention
por: Yu, Bingyan, et al.
Publicado: (2022)

D-Dimer Is Associated With Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease and Preserved Ejection Fraction
por: Lin, Yan, et al.
Publicado: (2022)

Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction
por: Zhou, Langping, et al.
Publicado: (2023)

Remnant cholesterol is associated with cardiovascular mortality
por: Zhang, Kerui, et al.
Publicado: (2022)

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
por: Baratta, Francesco, et al.
Publicado: (2023)

Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
por: Heo, Ji Hye, et al.
Publicado: (2023)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

Predictive effect of different blood lipid parameters combined with carotid intima-media thickness on coronary artery disease
por: Yu, Bingyan, et al.
Publicado: (2023)

Age dependent association between remnant cholesterol and cardiovascular disease
por: Wang, Anxin, et al.
Publicado: (2021)

Nonfasting remnant cholesterol and cardiovascular disease risk prediction in Albertans: a prospective cohort study
por: Weaver, Olivia R., et al.
Publicado: (2023)

Association between the Plasma-Glycosylated Hemoglobin A1c/High-Density Lipoprotein Cholesterol Ratio and Carotid Atherosclerosis: A Retrospective Study
por: Hu, Xiangming, et al.
Publicado: (2021)

Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study
por: Wadström, Benjamin N., et al.
Publicado: (2023)

Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without
por: Yu, Bingyan, et al.
Publicado: (2023)

Long-term trajectories of BMI and cumulative incident metabolic syndrome: A cohort study
por: Ying, Ming, et al.
Publicado: (2022)

The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes
por: Cao, Ye-Xuan, et al.
Publicado: (2020)

Contribution of Remnant Cholesterol to Coronary Atherosclerosis
por: Ohmura, Hirotoshi
Publicado: (2022)

Impact of Short-Term Heart Rate Variability in Patients with STEMI Treated by Delayed versus Immediate Stent in Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
por: Lin, Shaojie, et al.
Publicado: (2022)

Association between remnant cholesterol and heart failure: A prospective cohort study
por: Liu, Heng, et al.
Publicado: (2022)

Elevated Remnant Cholesterol is Associated with Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome
por: Shao, QiaoYu, et al.
Publicado: (2022)

Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population
por: Cheang, Iokfai, et al.
Publicado: (2022)

Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study
por: Wu, Weiqiang, et al.
Publicado: (2023)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Remnant Cholesterol Predicts Risk of Cardiovascular Events in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
por: Gao, Side, et al.
Publicado: (2022)

Remnant Cholesterol, a Valuable Biomarker for Assessing Arteriosclerosis and Cardiovascular Risk: A Systematic Review
por: Chen, Xiang, et al.
Publicado: (2023)

Remnant cholesterol, but not other cholesterol parameters, is associated with gestational diabetes mellitus in pregnant women: a prospective cohort study
por: Gao, Yajing, et al.
Publicado: (2023)

Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study
por: Hu, Xiangming, et al.
Publicado: (2020)

Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial
por: Lee, Eun-Jae, et al.
Publicado: (2020)

High Remnant Cholesterol Level Potentiates the Development of Hypertension
por: Chen, Ming-Ming, et al.
Publicado: (2022)

Association of remnant cholesterol with depression among US adults
por: Wang, Yang, et al.
Publicado: (2023)

Remnant cholesterol and severity of nonalcoholic fatty liver disease
por: Huang, Hangkai, et al.
Publicado: (2023)

Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations
por: Lütjohann, Dieter, et al.
Publicado: (2023)

The Association Between Remnant Cholesterol and the Estimated 10-Year Risk of a First Hard Cardiovascular Event
por: Yang, Zhen, et al.
Publicado: (2022)

Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study
por: Huh, Ji Hye, et al.
Publicado: (2022)

Post-prandial Remnant Lipoprotein Metabolism in Sitosterolemia
por: Tada, Hayato, et al.
Publicado: (2018)

Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol
por: Wu, Zhiyuan, et al.
Publicado: (2023)

B-Lines by Lung Ultrasound Can Predict Worsening Heart Failure in Acute Myocardial Infarction During Hospitalization and Short-Term Follow-Up
por: He, Jiexin, et al.
Publicado: (2022)

Separate and Joint Associations of Remnant Cholesterol Accumulation and Variability With Carotid Atherosclerosis: A Prospective Cohort Study
por: Wang, Jinqi, et al.
Publicado: (2023)

Remnant-Like Particle Cholesterol and the Risk of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Yang, Jie, et al.
Publicado: (2022)

Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0krfn1kn666re67tckfk0eoiui